Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01207 |
| Species: | Homo sapiens |
| Position : | chr6:30754822-30755196 |
| Year: | 2016 |
| Title: | A new class of temporarily phenotypic enhancers identified by CRISPR/Cas9-mediated genetic screening |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 26813977 |
| MONDO: | |
| Tissue: | Inner cell mass |
| Tissue Ontology ID: | UBERON:0000087 |
| Cell Source: | H1 human embryonic stem cells |
| CVCL ID: | CVCL_9771 |
| Cell Type: | embryonic stem cell |
| Cell Ontology ID: | CL:0002322 |
| Experiment Type: | Functional perturbation assay, Genetic screen |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | CRISPR Knockout |
| Target gene : | POU5F1 |
| TF name : | TEAD4 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| TEAD4 | PPARA activates gene expression | reactome | 113 |
| TEAD4 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | reactome | 29 |
| TEAD4 | Hs_VEGFA-VEGFR2_Signaling_Pathway_WP3888_90000 | wikipathways | 153 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00215 | chr6:30754822-30755196 | Ovary | ovarian carcinoma cell | ovarian carcinoma |